Skip to main content
Kevin Shee, MD, Urology, San Francisco, CA, San Francisco VA Medical Center

KevinSheeMDPhD

Urology San Francisco, CA

Urology Resident Physician at UCSF

Dr. Shee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shee's full profile

Already have an account?

Summary

  • https://www.ncbi.nlm.nih.gov/sites/myncbi/1JysDwbD9FyA_/bibliography/50610002/public/?sort=date&direction=ascending

Education & Training

  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 2020, MD-PhD
  • Harvard University
    Harvard UniversityBA, Molecular and Cellular Biology, Cum Laude, 2011

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2023 - 2025

Awards, Honors, & Recognition

  • S. Marsh Tenney Research Award Geisel School of Medicine at Dartmouth, 2020
  • 1st place winner - Surgical Trainees Advancing Research Symposium (STARS) DHMC Department of Surgery, 2019
  • John W. Strohbehn Medal for Excellence in Biomedical Research Geisel School of Medicine at Dartmouth, 2018
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • News Media Analysis of the United States Preventive Services Task Force and American Urological Association Prostate Cancer Screening Guidelines  
    Koo K, Shee K, Yap RL, Urology Practice, 12/10/2016

Abstracts/Posters

  • P6-07-03: Broken promise of liquid biopsy: Plasma DNA does not accurately reflect tumor DNA in metastatic breast cancer
    K Shee, MD Chamberlin, FS Varn, JR Bean, JD Marotti, WA Wells, HW Trask, JS Hamilton, RJ West, PA Kaufman, GN Schwartz, JM Gemery, NJ McNulty, MJ Tsapakos, RJ Barth, B..., Cancer Research - 2017
  • Abstract P3-03-01: A novel high-throughput secreted factor screen and bioinformatics pipeline identifies microenvironment-derived FGF2 as a mechanism of resistance to ...
    K Shee, JW Hinds, RA Hampsch, TR Golub, R Straussman and TW Miller, Cancer Research - 2017
  • Abstract P1-07-04: Unique overlapping subtypes of triple-negative breast and ovarian cancers and sensitivity of “mesenchymal-like” cancers to HSP90 inhibition is revea...
    K Shee, MH Ung, C Cheng and TW Miller, Cancer Research - 2017
  • Join now to see all

Grant Support

  • Microenvironmental FGF2-mediated resistance to anti-estrogen and PI3K/mTOR pathway therapeutics in ER+ breast cancerNIH2017–2021

Professional Memberships

Hospital Affiliations